PubMed:9872676
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-69 | Sentence | denotes | Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. |
| T2 | 70-134 | Sentence | denotes | Interleukin-10 (IL-10) protects animals from lethal endotoxemia. |
| T3 | 135-281 | Sentence | denotes | This beneficial effect is mediated, in part, by inhibition of inflammatory cytokine production, including tumor necrosis factor-alpha (TNF-alpha). |
| T4 | 282-425 | Sentence | denotes | Evidence suggests that IL-10 may inhibit activation of the transcription factor nuclear factor-kappaB (NF-kappaB) through an unknown mechanism. |
| T5 | 426-591 | Sentence | denotes | NF-kappaB activation in response to inflammatory signals is dependent upon degradation of its associated inhibitory peptide, inhibitory kappaB-alpha (IkappaB-alpha). |
| T6 | 592-733 | Sentence | denotes | We hypothesized that IL-10 prevents human monocyte NF-kappaB activation and resultant TNF-alpha production by stabilization of IkappaB-alpha. |
| T7 | 734-922 | Sentence | denotes | The purpose of this study was to determine the effect of IL-10 on lipopolysaccharide (LPS)-induced human monocyte TNF-alpha production, NF-kappaB activation, and IkappaB-alpha degradation. |
| T8 | 923-965 | Sentence | denotes | Monocytes were isolated from human donors. |
| T9 | 966-1060 | Sentence | denotes | Cells were stimulated with endotoxin (LPS, 100 ng/mL) with and without human IL-10 (10 ng/mL). |
| T10 | 1061-1239 | Sentence | denotes | Following stimulation, TNF-alpha was measured in cell supernatants by ELISA, NF-kappaB activity by electrophoretic mobility shift assay, and IkappaB-alpha levels by Western blot. |
| T11 | 1240-1363 | Sentence | denotes | We observed that after LPS stimulation of human monocytes, TNF-alpha increased to 798+/-67 pg/mL (p < .001 versus control). |
| T12 | 1364-1455 | Sentence | denotes | IL-10 attenuated LPS-stimulated TNF-alpha production (297+/-54; p < .001 versus LPS alone). |
| T13 | 1456-1574 | Sentence | denotes | After LPS stimulation in human monocytes, IkappaB-alpha protein levels decreased, and NF-kappaB DNA binding increased. |
| T14 | 1575-1695 | Sentence | denotes | IL-10 pretreatment prevented LPS-induced decreases in IkappaB-alpha protein levels and attenuated NF-kappaB DNA binding. |
| T15 | 1696-1833 | Sentence | denotes | IL-10 appears to prevent activation of NF-kappaB by preserving IkappaB-alpha protein levels, leading to a reduction in TNF-alpha release. |
| T1 | 0-69 | Sentence | denotes | Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. |
| T2 | 70-134 | Sentence | denotes | Interleukin-10 (IL-10) protects animals from lethal endotoxemia. |
| T3 | 135-281 | Sentence | denotes | This beneficial effect is mediated, in part, by inhibition of inflammatory cytokine production, including tumor necrosis factor-alpha (TNF-alpha). |
| T4 | 282-425 | Sentence | denotes | Evidence suggests that IL-10 may inhibit activation of the transcription factor nuclear factor-kappaB (NF-kappaB) through an unknown mechanism. |
| T5 | 426-591 | Sentence | denotes | NF-kappaB activation in response to inflammatory signals is dependent upon degradation of its associated inhibitory peptide, inhibitory kappaB-alpha (IkappaB-alpha). |
| T6 | 592-733 | Sentence | denotes | We hypothesized that IL-10 prevents human monocyte NF-kappaB activation and resultant TNF-alpha production by stabilization of IkappaB-alpha. |
| T7 | 734-922 | Sentence | denotes | The purpose of this study was to determine the effect of IL-10 on lipopolysaccharide (LPS)-induced human monocyte TNF-alpha production, NF-kappaB activation, and IkappaB-alpha degradation. |
| T8 | 923-965 | Sentence | denotes | Monocytes were isolated from human donors. |
| T9 | 966-1060 | Sentence | denotes | Cells were stimulated with endotoxin (LPS, 100 ng/mL) with and without human IL-10 (10 ng/mL). |
| T10 | 1061-1239 | Sentence | denotes | Following stimulation, TNF-alpha was measured in cell supernatants by ELISA, NF-kappaB activity by electrophoretic mobility shift assay, and IkappaB-alpha levels by Western blot. |
| T11 | 1240-1363 | Sentence | denotes | We observed that after LPS stimulation of human monocytes, TNF-alpha increased to 798+/-67 pg/mL (p < .001 versus control). |
| T12 | 1364-1455 | Sentence | denotes | IL-10 attenuated LPS-stimulated TNF-alpha production (297+/-54; p < .001 versus LPS alone). |
| T13 | 1456-1574 | Sentence | denotes | After LPS stimulation in human monocytes, IkappaB-alpha protein levels decreased, and NF-kappaB DNA binding increased. |
| T14 | 1575-1695 | Sentence | denotes | IL-10 pretreatment prevented LPS-induced decreases in IkappaB-alpha protein levels and attenuated NF-kappaB DNA binding. |
| T15 | 1696-1833 | Sentence | denotes | IL-10 appears to prevent activation of NF-kappaB by preserving IkappaB-alpha protein levels, leading to a reduction in TNF-alpha release. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-14 | protein | denotes | Interleukin-10 |
| T2 | 37-49 | protein | denotes | kappaB-alpha |
| T3 | 53-68 | cell_type | denotes | human monocytes |
| T4 | 70-84 | protein | denotes | Interleukin-10 |
| T5 | 86-91 | protein | denotes | IL-10 |
| T6 | 197-218 | protein | denotes | inflammatory cytokine |
| T7 | 241-268 | protein | denotes | tumor necrosis factor-alpha |
| T8 | 270-279 | protein | denotes | TNF-alpha |
| T9 | 305-310 | protein | denotes | IL-10 |
| T10 | 341-361 | protein | denotes | transcription factor |
| T11 | 362-383 | protein | denotes | nuclear factor-kappaB |
| T12 | 385-394 | protein | denotes | NF-kappaB |
| T13 | 426-435 | protein | denotes | NF-kappaB |
| T14 | 551-574 | protein | denotes | inhibitory kappaB-alpha |
| T15 | 576-589 | protein | denotes | IkappaB-alpha |
| T16 | 613-618 | protein | denotes | IL-10 |
| T17 | 643-652 | protein | denotes | NF-kappaB |
| T18 | 678-687 | protein | denotes | TNF-alpha |
| T19 | 719-732 | protein | denotes | IkappaB-alpha |
| T20 | 791-796 | protein | denotes | IL-10 |
| T21 | 848-857 | protein | denotes | TNF-alpha |
| T22 | 870-879 | protein | denotes | NF-kappaB |
| T23 | 896-909 | protein | denotes | IkappaB-alpha |
| T24 | 993-1002 | protein | denotes | endotoxin |
| T25 | 1043-1048 | protein | denotes | IL-10 |
| T26 | 1084-1093 | protein | denotes | TNF-alpha |
| T27 | 1138-1147 | protein | denotes | NF-kappaB |
| T28 | 1202-1215 | protein | denotes | IkappaB-alpha |
| T29 | 1282-1297 | cell_type | denotes | human monocytes |
| T30 | 1299-1308 | protein | denotes | TNF-alpha |
| T31 | 1364-1369 | protein | denotes | IL-10 |
| T32 | 1396-1405 | protein | denotes | TNF-alpha |
| T33 | 1481-1496 | cell_type | denotes | human monocytes |
| T34 | 1498-1511 | protein | denotes | IkappaB-alpha |
| T35 | 1542-1551 | protein | denotes | NF-kappaB |
| T36 | 1575-1580 | protein | denotes | IL-10 |
| T37 | 1629-1642 | protein | denotes | IkappaB-alpha |
| T38 | 1673-1682 | protein | denotes | NF-kappaB |
| T39 | 1696-1701 | protein | denotes | IL-10 |
| T40 | 1735-1744 | protein | denotes | NF-kappaB |
| T41 | 1759-1772 | protein | denotes | IkappaB-alpha |
| T42 | 1815-1824 | protein | denotes | TNF-alpha |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-14 | NP | denotes | Interleukin-10 |
| C2 | 26-49 | NP | denotes | inhibitory kappaB-alpha |
| C3 | 53-68 | NP | denotes | human monocytes |
| C4 | 70-92 | NP | denotes | Interleukin-10 (IL-10) |
| C5 | 241-280 | NP | denotes | tumor necrosis factor-alpha (TNF-alpha) |
| C6 | 305-310 | NP | denotes | IL-10 |
| C7 | 323-395 | NP | denotes | activation of the transcription factor nuclear factor-kappaB (NF-kappaB) |
| C8 | 426-446 | NP | denotes | NF-kappaB activation |
| C10 | 516-519 | NP | denotes | its |
| C9 | 516-549 | NP | denotes | its associated inhibitory peptide |
| C11 | 551-590 | NP | denotes | inhibitory kappaB-alpha (IkappaB-alpha) |
| C12 | 613-618 | NP | denotes | IL-10 |
| C13 | 628-663 | NP | denotes | human monocyte NF-kappaB activation |
| C14 | 719-732 | NP | denotes | IkappaB-alpha |
| C15 | 791-796 | NP | denotes | IL-10 |
| C16 | 800-868 | NP | denotes | lipopolysaccharide (LPS)-induced human monocyte TNF-alpha production |
| C17 | 870-890 | NP | denotes | NF-kappaB activation |
| C18 | 923-932 | NP | denotes | Monocytes |
| C19 | 1037-1048 | NP | denotes | human IL-10 |
| C20 | 1084-1093 | NP | denotes | TNF-alpha |
| C21 | 1282-1297 | NP | denotes | human monocytes |
| C22 | 1299-1308 | NP | denotes | TNF-alpha |
| C23 | 1364-1369 | NP | denotes | IL-10 |
| C24 | 1381-1416 | NP | denotes | LPS-stimulated TNF-alpha production |
| C25 | 1481-1496 | NP | denotes | human monocytes |
| C26 | 1498-1526 | NP | denotes | IkappaB-alpha protein levels |
| C27 | 1542-1563 | NP | denotes | NF-kappaB DNA binding |
| C28 | 1629-1657 | NP | denotes | IkappaB-alpha protein levels |
| C29 | 1673-1694 | NP | denotes | NF-kappaB DNA binding |
| C30 | 1696-1701 | NP | denotes | IL-10 |
| C31 | 1721-1744 | NP | denotes | activation of NF-kappaB |
| C32 | 1759-1787 | NP | denotes | IkappaB-alpha protein levels |
| R1 | C4 | C1 | coref-ident | Interleukin-10 (IL-10),Interleukin-10 |
| R2 | C6 | C4 | coref-ident | IL-10,Interleukin-10 (IL-10) |
| R3 | C10 | C8 | coref-pron | its,NF-kappaB activation |
| R4 | C9 | C2 | coref-ident | its associated inhibitory peptide,inhibitory kappaB-alpha |
| R5 | C11 | C9 | coref-appos | inhibitory kappaB-alpha (IkappaB-alpha),its associated inhibitory peptide |
| R6 | C12 | C6 | coref-ident | IL-10,IL-10 |
| R7 | C13 | C7 | coref-ident | human monocyte NF-kappaB activation,activation of the transcription factor nuclear factor-kappaB (NF-kappaB) |
| R8 | C14 | C11 | coref-ident | IkappaB-alpha,inhibitory kappaB-alpha (IkappaB-alpha) |
| R9 | C15 | C12 | coref-ident | IL-10,IL-10 |
| R10 | C17 | C13 | coref-ident | NF-kappaB activation,human monocyte NF-kappaB activation |
| R11 | C18 | C3 | coref-ident | Monocytes,human monocytes |
| R12 | C19 | C15 | coref-ident | human IL-10,IL-10 |
| R13 | C20 | C5 | coref-ident | TNF-alpha,tumor necrosis factor-alpha (TNF-alpha) |
| R14 | C21 | C18 | coref-ident | human monocytes,Monocytes |
| R15 | C22 | C20 | coref-ident | TNF-alpha,TNF-alpha |
| R16 | C23 | C19 | coref-ident | IL-10,human IL-10 |
| R17 | C24 | C16 | coref-ident | LPS-stimulated TNF-alpha production,lipopolysaccharide (LPS)-induced human monocyte TNF-alpha production |
| R18 | C25 | C21 | coref-ident | human monocytes,human monocytes |
| R19 | C28 | C26 | coref-ident | IkappaB-alpha protein levels,IkappaB-alpha protein levels |
| R20 | C29 | C27 | coref-ident | NF-kappaB DNA binding,NF-kappaB DNA binding |
| R21 | C30 | C23 | coref-ident | IL-10,IL-10 |
| R22 | C31 | C17 | coref-ident | activation of NF-kappaB,NF-kappaB activation |
| R23 | C32 | C28 | coref-ident | IkappaB-alpha protein levels,IkappaB-alpha protein levels |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-69 | Sentence | denotes | Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. |
| S2 | 70-134 | Sentence | denotes | Interleukin-10 (IL-10) protects animals from lethal endotoxemia. |
| S3 | 135-281 | Sentence | denotes | This beneficial effect is mediated, in part, by inhibition of inflammatory cytokine production, including tumor necrosis factor-alpha (TNF-alpha). |
| S4 | 282-425 | Sentence | denotes | Evidence suggests that IL-10 may inhibit activation of the transcription factor nuclear factor-kappaB (NF-kappaB) through an unknown mechanism. |
| S5 | 426-591 | Sentence | denotes | NF-kappaB activation in response to inflammatory signals is dependent upon degradation of its associated inhibitory peptide, inhibitory kappaB-alpha (IkappaB-alpha). |
| S6 | 592-733 | Sentence | denotes | We hypothesized that IL-10 prevents human monocyte NF-kappaB activation and resultant TNF-alpha production by stabilization of IkappaB-alpha. |
| S7 | 734-922 | Sentence | denotes | The purpose of this study was to determine the effect of IL-10 on lipopolysaccharide (LPS)-induced human monocyte TNF-alpha production, NF-kappaB activation, and IkappaB-alpha degradation. |
| S8 | 923-965 | Sentence | denotes | Monocytes were isolated from human donors. |
| S9 | 966-1060 | Sentence | denotes | Cells were stimulated with endotoxin (LPS, 100 ng/mL) with and without human IL-10 (10 ng/mL). |
| S10 | 1061-1239 | Sentence | denotes | Following stimulation, TNF-alpha was measured in cell supernatants by ELISA, NF-kappaB activity by electrophoretic mobility shift assay, and IkappaB-alpha levels by Western blot. |
| S11 | 1240-1363 | Sentence | denotes | We observed that after LPS stimulation of human monocytes, TNF-alpha increased to 798+/-67 pg/mL (p < .001 versus control). |
| S12 | 1364-1455 | Sentence | denotes | IL-10 attenuated LPS-stimulated TNF-alpha production (297+/-54; p < .001 versus LPS alone). |
| S13 | 1456-1574 | Sentence | denotes | After LPS stimulation in human monocytes, IkappaB-alpha protein levels decreased, and NF-kappaB DNA binding increased. |
| S14 | 1575-1695 | Sentence | denotes | IL-10 pretreatment prevented LPS-induced decreases in IkappaB-alpha protein levels and attenuated NF-kappaB DNA binding. |
| S15 | 1696-1833 | Sentence | denotes | IL-10 appears to prevent activation of NF-kappaB by preserving IkappaB-alpha protein levels, leading to a reduction in TNF-alpha release. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-14 | protein_molecule | denotes | Interleukin-10 |
| T2 | 37-49 | protein_molecule | denotes | kappaB-alpha |
| T3 | 53-68 | cell_type | denotes | human monocytes |
| T4 | 70-84 | protein_molecule | denotes | Interleukin-10 |
| T5 | 86-91 | protein_molecule | denotes | IL-10 |
| T6 | 115-133 | other_name | denotes | lethal endotoxemia |
| T7 | 197-218 | protein_family_or_group | denotes | inflammatory cytokine |
| T8 | 241-268 | protein_molecule | denotes | tumor necrosis factor-alpha |
| T9 | 270-279 | protein_molecule | denotes | TNF-alpha |
| T10 | 305-310 | protein_molecule | denotes | IL-10 |
| T11 | 341-361 | protein_family_or_group | denotes | transcription factor |
| T12 | 362-383 | protein_molecule | denotes | nuclear factor-kappaB |
| T13 | 385-394 | protein_complex | denotes | NF-kappaB |
| T14 | 426-435 | protein_complex | denotes | NF-kappaB |
| T15 | 462-482 | other_name | denotes | inflammatory signals |
| T16 | 531-549 | peptide | denotes | inhibitory peptide |
| T17 | 551-574 | protein_molecule | denotes | inhibitory kappaB-alpha |
| T18 | 576-589 | protein_molecule | denotes | IkappaB-alpha |
| T19 | 613-618 | protein_molecule | denotes | IL-10 |
| T20 | 628-642 | other_name | denotes | human monocyte |
| T21 | 643-652 | protein_complex | denotes | NF-kappaB |
| T22 | 678-687 | protein_molecule | denotes | TNF-alpha |
| T23 | 719-732 | protein_molecule | denotes | IkappaB-alpha |
| T24 | 791-796 | protein_molecule | denotes | IL-10 |
| T25 | 819-847 | other_name | denotes | (LPS)-induced human monocyte |
| T26 | 848-857 | protein_molecule | denotes | TNF-alpha |
| T27 | 870-879 | protein_complex | denotes | NF-kappaB |
| T28 | 896-909 | protein_molecule | denotes | IkappaB-alpha |
| T29 | 952-964 | multi_cell | denotes | human donors |
| T30 | 993-1002 | protein_family_or_group | denotes | endotoxin |
| T31 | 1004-1007 | lipid | denotes | LPS |
| T32 | 1043-1048 | protein_molecule | denotes | IL-10 |
| T33 | 1084-1093 | protein_molecule | denotes | TNF-alpha |
| T34 | 1131-1136 | other_name | denotes | ELISA |
| T35 | 1138-1147 | protein_complex | denotes | NF-kappaB |
| T36 | 1160-1196 | other_name | denotes | electrophoretic mobility shift assay |
| T37 | 1202-1215 | protein_molecule | denotes | IkappaB-alpha |
| T38 | 1226-1238 | other_name | denotes | Western blot |
| T39 | 1263-1266 | lipid | denotes | LPS |
| T40 | 1282-1297 | cell_type | denotes | human monocytes |
| T41 | 1299-1308 | protein_molecule | denotes | TNF-alpha |
| T42 | 1364-1369 | protein_molecule | denotes | IL-10 |
| T43 | 1381-1384 | lipid | denotes | LPS |
| T44 | 1396-1405 | protein_molecule | denotes | TNF-alpha |
| T45 | 1444-1447 | lipid | denotes | LPS |
| T46 | 1462-1465 | lipid | denotes | LPS |
| T47 | 1481-1496 | cell_type | denotes | human monocytes |
| T48 | 1498-1511 | protein_molecule | denotes | IkappaB-alpha |
| T49 | 1542-1551 | protein_complex | denotes | NF-kappaB |
| T50 | 1575-1580 | protein_molecule | denotes | IL-10 |
| T51 | 1604-1607 | lipid | denotes | LPS |
| T52 | 1629-1642 | protein_molecule | denotes | IkappaB-alpha |
| T53 | 1673-1682 | protein_complex | denotes | NF-kappaB |
| T54 | 1696-1701 | protein_molecule | denotes | IL-10 |
| T55 | 1735-1744 | protein_complex | denotes | NF-kappaB |
| T56 | 1759-1772 | protein_molecule | denotes | IkappaB-alpha |
| T57 | 1815-1824 | protein_molecule | denotes | TNF-alpha |